Insider Transactions in Q4 2023 at Novo Cure LTD (NVCR)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 31
2023
|
Wilhelmus Cm Groenhuysen Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.0%
|
$36
$12.69 P/Share
|
Dec 31
2023
|
Barak Ben Arye General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
128
+0.36%
|
$1,536
$12.69 P/Share
|
Nov 07
2023
|
Pritesh Shah Chief Growth Officer |
SELL
Open market or private sale
|
Direct |
382
-0.31%
|
$4,584
$12.65 P/Share
|
Nov 02
2023
|
Ashley Cordova Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
175
+0.15%
|
$1,925
$11.46 P/Share
|
Oct 31
2023
|
Michal Nath Puri Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,593
+50.0%
|
-
|
Oct 31
2023
|
Ashley Cordova Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,793
+5.0%
|
$177,930
$10.02 P/Share
|